ROYAL BANK OF CANADA - AYALA PHARMACEUTICALS INC ownership

AYALA PHARMACEUTICALS INC's ticker is AYLA and the CUSIP is 05465V108. A total of 13 filers reported holding AYALA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of AYALA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$14,000
+180.0%
1,250
+172.3%
0.00%
Q3 2020$5,0004590.00%
Other shareholders
AYALA PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Sio Capital Management, LLC 542,977$5,533,0001.38%
SILVERARC CAPITAL MANAGEMENT, LLC 23,364$238,0000.11%
Redmile Group, LLC 667,816$6,805,0000.10%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 31,962$326,0000.01%
Marshall Wace North America L.P. 49,266$502,0000.00%
WELLINGTON MANAGEMENT GROUP LLP 704,363$7,178,0000.00%
Chevy Chase Trust Holdings, LLC 15,000$153,0000.00%
Tower Research Capital LLC (TRC) 470$4,0000.00%
UBS Group AG 5,509$56,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of AYALA PHARMACEUTICALS INC shareholders